Spinal Research welcomes the development of new £10m medical research centre
The Government is to announce the setting up of a £10m science research centre on the site of the Olympic drug-testing laboratories in Harlow, Essex.
The “phenome” facility will be used for research into biological markers for health and disease.
Jonathan Miall, Chief Executive of Spinal Research, commented: “We welcome the Government’s plans to develop a £10m science research centre on the site of the Olympic drug-testing laboratories.
“We recognise the importance of funding medical research to make a tangible difference to people’s lives. Since our establishment 30 years ago, we have overseen many scientific breakthroughs and now stand on the brink of clinical trials that will potentially restore movement and feeling to the 50,000 people living with paralysis as result of spinal cord injury in the UK and Ireland. Those clinical trials will not take place without the critical support of the government of the day.
“This will be a lasting legacy of the London 2012 Games and has the potential not only to transform the lives of people living with a wide range of health conditions, but to provide a lead initiative for future development.”
The centre, run by drugs firm GlaxoSmithKline, will be funded by £10m over five years from the Medical Research Council and the Department of Health’s National Institute for Health Research.